Immunovant, Inc.
IMVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764013
In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Immunovant, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 133
- +21 vs. Q3 2022
- Shares held
- 56.5M
- +13.9M (+32.5%) vs. Q3 2022
- Total value
- $1.00B
- +$765.2M (+321.4%) vs. Q3 2022
- New holders
- 39
- 53 more added
- Sold out
- 18
- 28 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 226 | $4.25B |
| Q1 2026 | 216 | $2.75B |
| Q4 2025 | 197 | $2.76B |
| Q3 2025 | 186 | $1.53B |
| Q2 2025 | 169 | $1.54B |
| Q1 2025 | 194 | $1.62B |
| Q4 2024 | 187 | $1.98B |
| Q3 2024 | 182 | $2.26B |
| Q2 2024 | 197 | $1.97B |
| Q1 2024 | 209 | $2.27B |
| Q4 2023 | 228 | $2.88B |
| Q3 2023 | 181 | $2.57B |
| Q2 2023 | 147 | $1.05B |
| Q1 2023 | 142 | $903.7M |
| Q4 2022 | 133 | $1.00B |
| Q3 2022 | 112 | $238.1M |
| Q2 2022 | 94 | $156.5M |
| Q1 2022 | 112 | $218.6M |
| Q4 2021 | 118 | $322.4M |
| Q3 2021 | 119 | $293.6M |
| Q2 2021 | 110 | $407.5M |
| Q1 2021 | 120 | $654.3M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Immunovant, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | 323,918 | $5.75M | 0.00% | +145,490+81.5% | Added |
| Renaissance Technologies LLC | 344,100 | $6.11M | 0.01% | −8,400−2.4% | Reduced |
| Two Sigma Investments, LP | 357,037 | $6.34M | 0.02% | +98,470+38.1% | Added |
| Goldman Sachs Group Inc | 371,248 | $6.59M | 0.00% | +300,179+422.4% | Added |
| Balyasny Asset Management LLC | 375,775 | $6.67M | 0.02% | +222,272+144.8% | Added |
| Two Sigma Advisers, LP | 380,900 | $6.76M | 0.02% | +39,600+11.6% | Added |
| Charles Schwab Investment Management Inc | 386,654 | $6.86M | 0.00% | +81,679+26.8% | Added |
| Cormorant Asset Management, LP | 400,000 | $7.10M | 0.48% | +400,000 | New |
| Platinum Investment Management Ltd | 411,297 | $7.30M | 0.28% | −247,778−37.6% | Reduced |
| Northern Trust Corp | 417,943 | $7.42M | 0.00% | +68,068+19.5% | Added |
| Point72 Asset Management, L.P. | 435,751 | $7.73M | 0.03% | −1,531,549−77.9% | Reduced |
| Silverarc Capital Management, LLC | 519,614 | $9.22M | 3.18% | +219,614+73.2% | Added |
| Polar Asset Management Partners Inc. | 528,000 | $9.37M | 0.13% | +528,000 | New |
| Walleye Capital LLC | 533,840 | $9.48M | 0.21% | +366,270+218.6% | Added |
| Frazier Life Sciences Management, L.P. | 585,759 | $10.4M | 0.65% | 00.0% | Unchanged |
| Woodline Partners LP | 816,959 | $14.5M | 0.20% | −947,331−53.7% | Reduced |
| TCG Crossover Management, LLC | 854,853 | $15.2M | 2.68% | +854,853 | New |
| Ikarian Capital, LLC | 966,700 | $17.2M | 7.12% | +155,000+19.1% | Added |
| Citadel Advisors LLC | 972,722 | $17.3M | 0.02% | +901,589+1,267.5% | Added |
| Geode Capital Management, LLC | 1,003,595 | $17.8M | 0.00% | +189,926+23.3% | Added |
| Redmile Group, LLC | 1,088,131 | $19.3M | 0.79% | +1,088,131 | New |
| Commodore Capital LP | 1,150,505 | $20.4M | 3.08% | +1,150,505 | New |
| Cowen and Company, LLC | 1,250,000 | $22.2M | 2.35% | +1,250,000 | New |
| Dimensional Fund Advisors LP | 1,297,608 | $23.0M | 0.01% | +239,149+22.6% | Added |
| Alpine Global Management, LLC | 1,500,000 | $26.6M | 8.85% | −2,848,017−65.5% | Reduced |
| FMR LLC | 2,488,133 | $44.2M | 0.00% | +2,487,410+344,040.1% | Added |
| BVF Inc | 2,561,000 | $45.5M | 1.92% | +2,561,000 | New |
| State Street Corp | 3,112,943 | $55.3M | 0.00% | +2,234,342+254.3% | Added |
| Logos Global Management LP | 3,150,000 | $55.9M | 6.55% | +3,150,000 | New |
| Eventide Asset Management, LLC | 3,693,720 | $65.6M | 1.29% | −1,678,792−31.2% | Reduced |
| BlackRock Inc. | 3,929,424 | $69.7M | 0.00% | +422,750+12.1% | Added |
| Vanguard Group Inc | 5,069,119 | $90.0M | 0.00% | +1,068,669+26.7% | Added |
| Deep Track Capital, LP | 9,710,000 | $172.4M | 7.51% | −150,246−1.5% | Reduced |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −579,061−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −143,690−100.0% | Sold out |
| Wittenberg Investment Management, Inc. | 0 | $0 | 0.00% | −107,498−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −95,146−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −94,400−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −82,741−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −57,027−100.0% | Sold out |
| BCK Capital Management LP | 0 | $0 | 0.00% | −54,293−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −22,776−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −12,400−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −10,777−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −6,350−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −4,066−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −243−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −123−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −10−100.0% | Sold out |